Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
47.90
-1.15 (-2.34%)
May 13, 2025, 1:30 PM CST
-31.08%
Market Cap 6.18B
Revenue (ttm) 167.49M
Net Income (ttm) -206.66M
Shares Out 129.09M
EPS (ttm) -1.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 63,830
Average Volume 48,953
Open 49.20
Previous Close 49.05
Day's Range 47.90 - 49.20
52-Week Range 38.65 - 82.70
Beta 0.58
RSI 44.57
Earnings Date May 15, 2025

About Pharmosa Biopharm

Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It develops L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, T... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6875
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.